These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 21451107)
1. Opposite effects of endogenous peptide-MHC class I on T cell activity in the presence and absence of CD8. Stone JD; Aggen DH; Chervin AS; Narayanan S; Schmitt TM; Greenberg PD; Kranz DM J Immunol; 2011 May; 186(9):5193-200. PubMed ID: 21451107 [TBL] [Abstract][Full Text] [Related]
2. Cellular uptake followed by class I MHC presentation of some exogenous peptides contributes to T cell stimulatory capacity. Brophy SE; Jones LL; Holler PD; Kranz DM Mol Immunol; 2007 Mar; 44(9):2184-94. PubMed ID: 17169430 [TBL] [Abstract][Full Text] [Related]
3. The impact of TCR-binding properties and antigen presentation format on T cell responsiveness. Chervin AS; Stone JD; Holler PD; Bai A; Chen J; Eisen HN; Kranz DM J Immunol; 2009 Jul; 183(2):1166-78. PubMed ID: 19553539 [TBL] [Abstract][Full Text] [Related]
4. Engineering the binding properties of the T cell receptor:peptide:MHC ternary complex that governs T cell activity. Bowerman NA; Crofts TS; Chlewicki L; Do P; Baker BM; Christopher Garcia K; Kranz DM Mol Immunol; 2009 Sep; 46(15):3000-8. PubMed ID: 19595460 [TBL] [Abstract][Full Text] [Related]
5. Allogeneic and syngeneic class I MHC complexes drive the association of CD8 and TCR on 2C T cells. Lee PU; Kranz DM Mol Immunol; 2003 Jan; 39(12):687-95. PubMed ID: 12531280 [TBL] [Abstract][Full Text] [Related]
6. MHC class I molecules with Superenhanced CD8 binding properties bypass the requirement for cognate TCR recognition and nonspecifically activate CTLs. Wooldridge L; Clement M; Lissina A; Edwards ES; Ladell K; Ekeruche J; Hewitt RE; Laugel B; Gostick E; Cole DK; Debets R; Berrevoets C; Miles JJ; Burrows SR; Price DA; Sewell AK J Immunol; 2010 Apr; 184(7):3357-66. PubMed ID: 20190139 [TBL] [Abstract][Full Text] [Related]
8. Quantitative analysis of the contribution of TCR/pepMHC affinity and CD8 to T cell activation. Holler PD; Kranz DM Immunity; 2003 Feb; 18(2):255-64. PubMed ID: 12594952 [TBL] [Abstract][Full Text] [Related]
9. CD8 T cells, like CD4 T cells, are triggered by multivalent engagement of TCRs by MHC-peptide ligands but not by monovalent engagement. Stone JD; Stern LJ J Immunol; 2006 Feb; 176(3):1498-505. PubMed ID: 16424178 [TBL] [Abstract][Full Text] [Related]
10. CD8(-) T cell transfectants that express a high affinity T cell receptor exhibit enhanced peptide-dependent activation. Holler PD; Lim AR; Cho BK; Rund LA; Kranz DM J Exp Med; 2001 Oct; 194(8):1043-52. PubMed ID: 11602635 [TBL] [Abstract][Full Text] [Related]
11. Glu227-->Lys substitution in the acidic loop of major histocompatibility complex class I alpha 3 domain distinguishes low avidity CD8 coreceptor and avidity-enhanced CD8 accessory functions. Shen L; Potter TA; Kane KP J Exp Med; 1996 Nov; 184(5):1671-83. PubMed ID: 8920857 [TBL] [Abstract][Full Text] [Related]
12. Critical role for CD8 in T cell receptor binding and activation by peptide/major histocompatibility complex multimers. Daniels MA; Jameson SC J Exp Med; 2000 Jan; 191(2):335-46. PubMed ID: 10637277 [TBL] [Abstract][Full Text] [Related]
13. CD8 controls T cell cross-reactivity. Wooldridge L; Laugel B; Ekeruche J; Clement M; van den Berg HA; Price DA; Sewell AK J Immunol; 2010 Oct; 185(8):4625-32. PubMed ID: 20844204 [TBL] [Abstract][Full Text] [Related]
14. Different T cell receptor affinity thresholds and CD8 coreceptor dependence govern cytotoxic T lymphocyte activation and tetramer binding properties. Laugel B; van den Berg HA; Gostick E; Cole DK; Wooldridge L; Boulter J; Milicic A; Price DA; Sewell AK J Biol Chem; 2007 Aug; 282(33):23799-810. PubMed ID: 17540778 [TBL] [Abstract][Full Text] [Related]
15. The CD8 T cell coreceptor exhibits disproportionate biological activity at extremely low binding affinities. Hutchinson SL; Wooldridge L; Tafuro S; Laugel B; Glick M; Boulter JM; Jakobsen BK; Price DA; Sewell AK J Biol Chem; 2003 Jul; 278(27):24285-93. PubMed ID: 12697765 [TBL] [Abstract][Full Text] [Related]
16. Long-term persistence of CD4(+) but rapid disappearance of CD8(+) T cells expressing an MHC class I-restricted TCR of nanomolar affinity. Engels B; Chervin AS; Sant AJ; Kranz DM; Schreiber H Mol Ther; 2012 Mar; 20(3):652-60. PubMed ID: 22233579 [TBL] [Abstract][Full Text] [Related]
17. CD8 coreceptor-mediated focusing can reorder the agonist hierarchy of peptide ligands recognized via the T cell receptor. Clement M; Knezevic L; Dockree T; McLaren JE; Ladell K; Miners KL; Llewellyn-Lacey S; Rubina A; Francis O; Cole DK; Sewell AK; Bridgeman JS; Price DA; van den Berg HA; Wooldridge L Proc Natl Acad Sci U S A; 2021 Jul; 118(29):. PubMed ID: 34272276 [TBL] [Abstract][Full Text] [Related]
18. Loss of CD8 and TCR binding to Class I MHC ligands following T cell activation. Kao C; Daniels MA; Jameson SC Int Immunol; 2005 Dec; 17(12):1607-17. PubMed ID: 16263755 [TBL] [Abstract][Full Text] [Related]
19. The MHC class II ligand lymphocyte activation gene-3 is co-distributed with CD8 and CD3-TCR molecules after their engagement by mAb or peptide-MHC class I complexes. Hannier S; Triebel F Int Immunol; 1999 Nov; 11(11):1745-52. PubMed ID: 10545478 [TBL] [Abstract][Full Text] [Related]
20. Generation of T cell help through a MHC class I-restricted TCR. Kessels HW; Schepers K; van den Boom MD; Topham DJ; Schumacher TN J Immunol; 2006 Jul; 177(2):976-82. PubMed ID: 16818753 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]